Your browser doesn't support javascript.
loading
Homology-driven genome editing in hematopoietic stem and progenitor cells using ZFN mRNA and AAV6 donors.
Wang, Jianbin; Exline, Colin M; DeClercq, Joshua J; Llewellyn, G Nicholas; Hayward, Samuel B; Li, Patrick Wai-Lun; Shivak, David A; Surosky, Richard T; Gregory, Philip D; Holmes, Michael C; Cannon, Paula M.
Afiliación
  • Wang J; Sangamo BioSciences, Inc., Richmond, California, USA.
  • Exline CM; Department of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
  • DeClercq JJ; Sangamo BioSciences, Inc., Richmond, California, USA.
  • Llewellyn GN; Department of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
  • Hayward SB; Sangamo BioSciences, Inc., Richmond, California, USA.
  • Li PW; Sangamo BioSciences, Inc., Richmond, California, USA.
  • Shivak DA; Sangamo BioSciences, Inc., Richmond, California, USA.
  • Surosky RT; Sangamo BioSciences, Inc., Richmond, California, USA.
  • Gregory PD; Sangamo BioSciences, Inc., Richmond, California, USA.
  • Holmes MC; Sangamo BioSciences, Inc., Richmond, California, USA.
  • Cannon PM; Department of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
Nat Biotechnol ; 33(12): 1256-1263, 2015 Dec.
Article en En | MEDLINE | ID: mdl-26551060
ABSTRACT
Genome editing with targeted nucleases and DNA donor templates homologous to the break site has proven challenging in human hematopoietic stem and progenitor cells (HSPCs), and particularly in the most primitive, long-term repopulating cell population. Here we report that combining electroporation of zinc finger nuclease (ZFN) mRNA with donor template delivery by adeno-associated virus (AAV) serotype 6 vectors directs efficient genome editing in HSPCs, achieving site-specific insertion of a GFP cassette at the CCR5 and AAVS1 loci in mobilized peripheral blood CD34+ HSPCs at mean frequencies of 17% and 26%, respectively, and in fetal liver HSPCs at 19% and 43%, respectively. Notably, this approach modified the CD34+CD133+CD90+ cell population, a minor component of CD34+ cells that contains long-term repopulating hematopoietic stem cells (HSCs). Genome-edited HSPCs also engrafted in immune-deficient mice long-term, confirming that HSCs are targeted by this approach. Our results provide a strategy for more robust application of genome-editing technologies in HSPCs.

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Nat Biotechnol Asunto de la revista: BIOTECNOLOGIA Año: 2015 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Nat Biotechnol Asunto de la revista: BIOTECNOLOGIA Año: 2015 Tipo del documento: Article País de afiliación: Estados Unidos